XML 38 R17.htm IDEA: XBRL DOCUMENT v3.2.0.727
WARRANTS
6 Months Ended
Jun. 30, 2015
Warrants  
WARRANTS

(11)       WARRANTS

 

In the three and six months ended June 30, 2015, the Company issued warrants to purchase 999,999 and 1,666,666 shares of our common stock, respectively, in connection with a partial closing related to the private placement of the Company’s Common Stock as well as the 333,333 shares of our common stock in connection with a Reimbursement Agreement. See Notes 6and7.

 

The Derivative Warrants to purchase 700,000 shares of our Common Stock, at exercise prices ranging from $20.00 to $22.70, and expiring in 2017, are included in the outstanding warrants at January 1, 2015. On February 12, 2015, these warrants were re-priced to $7.50 to compensate PPVA in connection with the Reimbursement Agreement reached between the Company and PPVA. See Notes 6 and 7.

 

A summary of warrant activity for the six months ended June 30, 2015 is as follows:

 

 

 

 

Warrants

 

 

 

 

Shares

   

Weighted-Average

Exercise Price

 
Outstanding warrants at January 1, 2015     1,847,066     $ 10.04  
Granted     1,999,999     $ 3.00  
Forfeited     (37,638 )   $ 22.50  
Outstanding warrants at June 30, 2015     3,809,427     $ 3.81  

 

At June 30, 2015, the Company had the following outstanding warrants:

 

 

Type of Warrant/ Range of

Exercise Prices

 

 

 

 

 

Expirations

 

 

 

Number Outstanding

    Weighted- Average Remaining Contractual Life (years)     Weighted- Average Exercise Price    

 

 

Number Exercisable

 
Derivative:                            
$ 7.50   8/31/17 to 11/6/17     700,000       2.23     $ 7.50       700,000  
Equity:                                    
$ 2.75 - $3.00   12/10/18 to 03/09/20     3,109,427       4.59     $ 2.98       3,109,427  
Total outstanding     3,809,427                       3,809,427  

 

The Company uses valuation methods and assumptions that consider among other factors the fair value of the underlying stock, risk-free interest rate, volatility, expected life and dividend rates in estimating fair value for the warrants considered to be derivative instruments. The following assumptions were utilized by the Company:

 

Risk-free interest rate .70 %
Expected dividend yield
Expected term - years (contractual term) 2.5
Forfeiture rate
Expected volatility 92 %

 

Expected volatilities are based on historical volatility of the Common Stock using historical periods consistent with the expected term of the warrant. The risk-free rate is based on the yield of a U.S. Treasury security with a term consistent with the warrant.